Shanghai, China

Haibo Qiu

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: His Pharmaceutical Co., Ltd., Shanghai Aryl Pharmtech Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Haibo Qiu. Retrieved from https://idiyas.com/inventor/haibo-qiu-g128l7cg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Haibo Qiu: Innovator in Alkyne Derivatives

Introduction

Haibo Qiu is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly through his work on alkyne derivatives. His innovative approach has led to advancements in therapeutic agents, specifically targeting phosphoinositide 3-kinase γ (PI3Kγ).

Latest Patents

Haibo Qiu holds 1 patent for his invention titled "Alkyne derivative, preparation method for same, and uses thereof." This patent details a novel alkyne derivative, its preparation method, and its applications in medicine. The invention focuses on the alkyne derivative represented by formula (I), which serves as a phosphoinositide 3-kinase γ (PI3Kγ) inhibitor, providing potential therapeutic benefits.

Career Highlights

Throughout his career, Haibo Qiu has worked with various pharmaceutical companies, including His Pharmaceutical Co., Ltd. and Shanghai Aryl Pharmtech Co., Ltd. His experience in these organizations has allowed him to collaborate with other professionals in the field and contribute to significant advancements in drug development.

Collaborations

Haibo Qiu has collaborated with notable colleagues, including Hejun Lv and Yutao Ma. These partnerships have fostered a productive environment for innovation and research in medicinal chemistry.

Conclusion

Haibo Qiu's work in alkyne derivatives exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions continue to pave the way for new therapeutic agents that may improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…